Our impact: Stories from 2025
Addressing cancer requires a continuum of research — from generating new discoveries, to advancing leading-edge treatments, to creating real-world insights — spanning the biology of a single tumour to the complexities of the entire health system. Across this spectrum, we are committed to advancing knowledge, transforming care and improving outcomes for every patient we serve.
In 2025, we are proud of the progress achieved across these areas of cancer research. The stories that follow showcase the dedication and impact of our investigators, trainees and research teams as they work collaboratively, with the generous support of our community, to confront the cancer challenge - together.
Our focus areas in 2025:
Learn more about some of the impacts we made in 2025:
Generating new discoveries and insights
- Pg. 10: Advancing precision oncology across the prairies and beyond
- Pg. 13: Uncovering protein structure to advance precision oncology: Launch of APACE
- Pg. 15: Unlocking new clues to improve targeted cancer therapies
- Pg. 16: Bringing novel detection to environmental exposures — a "most read" research story of 2025
- Pg. 17: Detecting breast cancer earlier: A new blood test for women at high risk
- Pg. 18: Redefining thyroid cancer care with Thyroid GuidePx®
- Pg. 19: Understanding patients with rare tumours: Focus on neuroendocrine and endocrine tumours
Advancing leading-edge treatments
- Pg. 21: Ohlson Research Initiative bridges evidence and care to advance head and neck cancer outcomes
- Pg. 22: Building Canadian-made CAR T-cell therapies for blood cancer
- Pg. 23: Extending the power of CAR T-cell therapy in multiple myeloma
- Pg. 26: Moving the needle on survivorships: Exercise, survival and leadership in colon cancer research
- Pg. 27: Advancing hope in glioblastoma: A promising new approach with NiacinCRT™
Creating real-world insights and impacts
- Pg. 28: Real-world evidence, real-world impact: Advancing cancer care through data and discovery
- Pg. 29: Understanding Canada's cancer landscape through national data
- Pg. 30: Global equity in focus: Redefining the cancer burden through data
- Pg. 31: Transforming lung cancer care through evidence, partnership and patient voices
- Pg. 32: Propelling precision radiation therapy through integrated research and care
- Pg. 33: Earlier support, better journeys: Expanding access to palliative care
- Pg. 34: Cultivating compassion across care: Redefining quality in health systems
- Pg. 35: Evaluating how best to empower patients during and beyond cancer treatment
Advancing precision oncology across the prairies and beyond
Uncovering protein structure to advance precision oncology: Launch of APACE
Unlocking new clues to improve targeted cancer therapies
Bringing novel detection to environmental exposures — a “most read” research story of 2025
Detecting breast cancer earlier: A new blood test for women at high risk
Redefining thyroid cancer care with Thyroid GuidePx®
Understanding patients with rare tumours: Focus on neuroendocrine and endocrine tumours
Ohlson Research Initiative bridges evidence and care to advance head and neck cancer outcomes
Building Canadian-made CAR T-cell therapies for blood cancer
Extending the power of CAR T-cell therapy in multiple myeloma
Moving the needle on survivorship: Exercise, survival and leadership in colon cancer research
Advancing hope in glioblastoma: A promising new approach with NiacinCRT™
Real-world evidence, real-world impact: Advancing cancer care through data and discovery
Understanding Canada's cancer landscape through national data
Global equity in focus: Redefining the cancer burden through data
Transforming lung cancer care through evidence, partnership and patient voices
Propelling precision radiation therapy through integrated research and care
Earlier support, better journeys: Expanding access to palliative care
Cultivating compassion across care: Redefining quality in health systems
Evaluating how best to empower patients during and beyond cancer treatment
